Clinical Trial

A Study to Evaluate Safety and Efficacy of PBK_M2502

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This clinical trial was prospective, randomized, single-blind, 3-treatment arm, parallel treatment group, and active-controlled. , Multi-center, Phase 3 confirmatory clinical trial.
Trial Details
NCT Number NCT07114406
Lead Sponsor Pharmbio Korea Co., Ltd.
Conditions Intestinal Disease, Colonic Diseases, Gastrointestinal Disease, Digestive System Disease
Enrollment 110 participants
Start Date 2025-08
Primary Completion 2026-08 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-08-11